Post job

Competitor Summary. See how National Hemophilia Foundation compares to its main competitors:

  • Cystic Fibrosis Foundation has the most employees (2,016).
Work at National Hemophilia Foundation?
Share your experience

National Hemophilia Foundation vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
1948
4.2
New York, NY1$25.2M126
Bleeding and Clotting Disorders Institute
2010
3.7
Peoria, IL1$50.0M4
1955
4.4
Bethesda, MD5$192.5M2,016
1977
4.2
Washington, DC1$13.6M161
Hemophilia Federation of America
1994
3.6
Washington, DC1$6.3M7
-
4.5
Framingham, MA1$50.0M75
-
4.2
Annandale, VA1$3.8M35
1997
4.0
Oakland, CA1$8.0M72
1965
4.3
Ashburn, VA1$50.0M62
1946
4.1
Lakeland, FL1$13.8M34
1938
4.1
New York, NY1$62.5M136
Arthritis Foundation
-
4.6
Atlanta, GA3$77.4M7
1920
3.8
Portland, OR1$33.3M68
Hillel International
1992
3.8
Tempe, AZ1$1.3M15
1911
3.7
Los Angeles, CA1$6.3M226
1946
4.2
Denver, CO11$181.2M1,000
1949
3.4
Towson, MD1$2.6M30
-
4.2
West Plains, MO1$24.0M350
Tidewater Jewish Foundation
1982
4.1
Virginia Beach, VA1$6.5M10
1987
3.9
Washington, DC1$5.0M184
1923
4.1
Columbus, OH1$53.4M125

Rate how well National Hemophilia Foundation differentiates itself from its competitors.

Zippia waving zebra

National Hemophilia Foundation salaries vs competitors

Compare National Hemophilia Foundation salaries vs competitors

CompanyAverage salaryHourly salarySalary score
National Hemophilia Foundation
$52,979$25.47-

Compare National Hemophilia Foundation job title salaries vs competitors

CompanyHighest salaryHourly salary
National Hemophilia Foundation
$34,743$16.70
Hemophilia Federation of America
$44,456$21.37
NESsT
$43,036$20.69
United Way of Central Ohio
$42,913$20.63
Not For Profit
$42,315$20.34
Jewish Federation of Greater Los Angeles
$40,952$19.69
United Way of Central Florida
$40,315$19.38
United Way of the Columbia-Willamette
$39,594$19.04
International Women's Forum
$39,206$18.85
National Multiple Sclerosis Society
$38,681$18.60
International Dyslexia Association
$35,637$17.13
Community Associations Institu
$34,768$16.72
Arthritis Foundation
$34,747$16.71
Tidewater Jewish Foundation
$34,733$16.70
Hillel International
$34,208$16.45
United Way of New York City
$32,948$15.84
American Lung Association Of The Northeast
$32,233$15.50
Bleeding and Clotting Disorders Institute
$31,708$15.24
Cystic Fibrosis Foundation
$31,431$15.11
National Recreation and Park Association
$31,368$15.08

Do you work at National Hemophilia Foundation?

Does National Hemophilia Foundation effectively differentiate itself from competitors?

National Hemophilia Foundation jobs

National Hemophilia Foundation demographics vs competitors

Compare gender at National Hemophilia Foundation vs competitors

Job titleMaleFemale
Arthritis Foundation23%77%
Lupus Foundation of America24%76%
Cystic Fibrosis Foundation24%76%
National Multiple Sclerosis Society27%73%
United Way of New York City31%69%
National Hemophilia Foundation45%55%

Compare race at National Hemophilia Foundation vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
53%23%11%11%2%
8.9
64%14%11%7%4%
8.8
Arthritis Foundation
62%13%13%8%4%
9.4
62%13%15%6%4%
9.1
58%12%15%11%4%
8.7
59%17%12%7%4%
8.9

National Hemophilia Foundation and similar companies CEOs

CEOBio

Cynthia Zagieboylo is a President & CEO at NATIONAL MULTIPLE SCLEROSIS SOCIETY and is based in United States. She has worked as Vice President, Chapter Programs at NATIONAL MULTIPLE SCLEROSIS SOCIETY and Chief Field Services Officer at NATIONAL MULTIPLE SCLEROSIS SOCIETY. Cynthia attended University of Connecticut between 1982 and 1984 and Springfield College between 1978 and 1982.

Steven Taylor
Arthritis Foundation

Michael Boyle, MD, is president and chief executive officer. Prior to his appointment as president and CEO, Dr. Boyle served as senior vice president, therapeutics development at the Cystic Fibrosis Foundation from 2015-2019. In that role, Dr. Boyle shaped the Foundation's clinical research strategy, overseeing the clinical development programs of new treatments for the CF Foundation, as well as the Foundation's Therapeutics Development Network of 92 academic research centers. Dr. Boyle is internationally known for his clinical research and for his work to improve care for adults with CF. He served as both an investigator in the clinical study of Kalydeco® and principal investigator of the pivotal trial that led to approval of the first combination treatment, Orkambi®. Dr. Boyle completed his medical training at Johns Hopkins University, including a fellowship in pulmonary and critical care medicine, before joining the medical faculty in 1999. Dr. Boyle founded the Johns Hopkins University Adult CF Program -- one of the largest in the United States -- in 1999 and served as director of that center for close to two decades. Today, he is an adjunct professor of medicine at Johns Hopkins, where he continues to see patients. In addition to his medical background, Dr. Boyle has completed training in nonprofit management at both Johns Hopkins and Harvard University.

Adam Lehman
Hillel International

Stephanie O'Keefe is a Chief Executive Officer at International Womens Forum and is based in Washington d.c. Metro Area. She has worked as Chief Communications Officer at CTIA; Associate at CS FIrst Boston; and Senior Vice President, Communications at Export-Import Bank of the United States. Stephanie attended Harvard Kennedy School and Harvard University.

Scott Kaplan
Tidewater Jewish Foundation

National Hemophilia Foundation competitors FAQs

Search for jobs